代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响

doi:10.19871/j.cnki.xfcrbzz.2023.01.006

新发传染病电子杂志 ›› 2023, Vol. 8 ›› Issue (1): 31-34.doi: 10.19871/j.cnki.xfcrbzz.2023.01.006

代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响

王宏霞¹, 王艳¹, 段瑞娴¹, 张建伟¹, 任圆²

1.山西医科大学第三医院（山西白求恩医院,山西医学科学院,同济山西医院）,山西太原 030032;
2.山西医科大学公共卫生学院,山西太原 030001

收稿日期:2022-08-22 出版日期:2023-02-28 发布日期:2023-03-30
通讯作者: 王艳,Email：wangyaner7711@163.com
基金资助:
中国肝炎基金会王宝恩肝纤维化研究基金（WBE20181030）

Effects of metabolic syndrome and its components on serum HBsAg levels in patients with chronic hepatitis B

Wang Hongxia¹, Wang Yan¹, Duan Ruixian¹, Zhang Jianwei¹, Ren Yuan²

1. Department of Infectious Diseases Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital,Shanxi Taiyuan 030032, China;
2. School of Public Health, Shanxi Medical University, Shanxi Taiyuan 030001,China

Received:2022-08-22 Online:2023-02-28 Published:2023-03-30

摘要/Abstract

摘要： 目的探讨代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响,为慢性乙型肝炎合并代谢综合征患者后续的慢性乙型肝炎临床治愈提供思路。方法选取2020年5月至2021年9月在山西白求恩医院感染病科确诊初治的415例患者进行回顾性分析。根据是否合并代谢综合征将其分为慢性乙型肝炎组（CHB组）,慢性乙型肝炎合并代谢综合征组（CHB合并MetS组）。收集患者的一般资料、生化指标、病毒学指标及肝脏瞬时弹性检查结果,通过非参数秩和检验、χ²检验及多元线性回归等分析代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响。结果 CHB组247例（59.50%）,CHB合并MetS组168例（40.50%）。多元线性回归结果显示：血糖及甘油三酯对血清HBsAg水平的影响有统计学意义（t=-3.25,P=0.001;t=2.25,P=0.025）,血压及腰围对血清HBsAg水平的影响差异无统计学意义。结论血糖负向预测慢性乙型肝炎患者血清HBsAg水平,甘油三酯正向预测慢性乙型肝炎患者血清HBsAg水平,而血压及腰围并不影响患者HBsAg水平。

关键词: 慢性乙型肝炎, 代谢综合征, 乙型肝炎表面抗原

Abstract: Objective To explore the effects of metabolic syndrome and its components on serum HBsAg levels in patients with chronic hepatitis B, so as to provide ideas for the subsequent clinical cure of chronic hepatitis B patients with metabolic syndrome. Method A retrospective analysis of 415 patients with chronic hepatitis B who were admitted to Shanxi Bethune Hospital from May 2019 to September 2020. They were divided into chronic hepatitis B group and chronic hepatitis B combined with metabolic syndrome group according to whether they were complicated with metabolic syndrome. The general data, biochemical parameters, virological parameters, and liver transient elasticity were collected. Non-parametric rank sum test, chi-square test and multiple linear regression were used to analyze the effects of metabolic syndrome and its components on serum HBsAg levels in patients with chronic hepatitis B. Result A total of 415 patients were included in this study, including 247 patients (59.50%) in CHB group and 168 patients (40.50%) in CHB combined with MetS group. The results of multiple linear regression showed that blood glucose and triglyceride had statistically significant effects on serum HBsAg level (t=-3.25, P=0.001; t=2.25, P=0.025), while blood pressure and waist circumference had no statistically significant effects on serum HBsAg level. Conclusion Blood glucose negatively predicted serum HBsAg level in CHB patients, triglyceride positively predicted serum HBsAg level in CHB patients, but blood pressure and waist circumference did not affect the level of HBsAg.

Key words: Chronic hepatitis B, Metabolic syndrome, Hepatitis B surface antigen

中图分类号:

R58
R512.6+2

王宏霞, 王艳, 段瑞娴, 张建伟, 任圆. 代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响[J]. 新发传染病电子杂志, 2023, 8(1): 31-34.

Wang Hongxia, Wang Yan, Duan Ruixian, Zhang Jianwei, Ren Yuan. Effects of metabolic syndrome and its components on serum HBsAg levels in patients with chronic hepatitis B[J]. Electronic Journal of Emerging Infectious Diseases, 2023, 8(1): 31-34.

参考文献

[1] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中国医学前沿杂志(电子版), 2019, 11(12):51-77.
[2] ZHOU K,CONTAG C,WHITAKER E,et al.Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: A systematic review and pooled meta–analyses[J]. Lancet Gastroenterol Hepatol, 2019, 4(3): 227–238.
[3] YEO YH, HO HJ, YANG HI, et al.Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: A systematic review and Meta–analysis[J]. Gastroenterology, 2019, 156(3):635–646.
[4] LU J, WANG L, LI M, et al.2010 China Noncommunicable Disease Surveillance Group. Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance[J]. J Clin Endocrinol Metab, 2017, 102(2): 507-515.
[5] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[6] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎临床治愈(功能性治愈)专家共识[J]. 中华传染病杂志, 2019, (8): 461-472.
[7] PETER J, SYLVIA D, JAN F, et al.Association between hepatitis B and metabolic syndrome:Current state of the art[J]. World J Gastroenterol, 2016, 63(1): 155-164.
[8] 吴琦琦, 马燕, 王晓波, 等. 代谢综合征对慢性乙型肝炎患者显著肝纤维化的影响[J]. 临床肝胆病杂志, 2018, 34(12): 2572-2577.
[9] ZHANG JB, LIN SZ, JIANG DX, et al.Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?[J]. Liver Inter, 2020, 40(3): 496-508.
[10] LIM CT, KUMAR R.Hepatitis B and concomitant hepatic steatosis[J]. Ann Transl Med, 2017, 5: 38.
[11] FELDSTEIN AE, CANBAY A, ANGULO P, et al.Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis[J]. Gastroenterology, 2003, 125(2): 437-443.
[12] ZHANG Z, PAN Q, DUAN XY, et al.Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model[J]. J Gastroenterol Hepatol, 2012, 27(12): 1858-1864.
[13] HSUEH RC, WU WJ, LIN CL, et al.Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B[J]. J Hepatocell Carcinoma, 2022, 11(9): 301-313.
[14] HU D, WANG H, WANG H,et al.Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model[J]. Hepatol Int, 2018, 12(5): 438-446.
[15] HSIANG J, WONG GL, CHAN HL, et al.Editorial: metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B--authors' reply[J]. Aliment Pharmacol Ther, 2014, 40(8): 983.
[16] 杨玲玲, 何金秋, 张雪珍. 乙型肝炎肝硬化合并2型糖尿病预后分析[J]. 中华传染病杂志, 2016, 34(1): 10-14.
[17] 柴艳云, 张锦前, 凌伟, 等. 慢性乙型肝炎伴发代谢综合征影响因素分析[J/CD]. 中华实验和临床感染病杂志(电子版), 2009, 3(1): 50-55.
[18] PETTA S, MACALUSO FS, BARCELLONA MR, et al.Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases[J]. PLoS One, 2012, 7(12): e51165.
[19] MARINO L, JORNAYVAZ FR.Endocrine causes of nonalcoholic fatty liver disease[J]. World J Gastroenterol, 2015, 21(39): 11053-11076.
[20] LIU J, LEE MH, BATRLA-UTERMANN R, et al.A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection[J]. J Hepatol, 2013, 58(5): 853-860.
[21] MAK LY, HUI RW, FUNG J, et al.Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B[J]. J Hepatol, 2020, 73(4): 800-806.

代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响

Effects of metabolic syndrome and its components on serum HBsAg levels in patients with chronic hepatitis B

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	李延东, 范荣山. 谷丙转氨酶持续正常的慢性乙型肝炎病毒感染者肝脏病理特征及预测因素[J]. 新发传染病电子杂志, 2023, 8(1): 44-47.
[2]	丁霞, 廖桂婵, 夏牧晔, 彭劼. 探讨长期核苷（酸）类药物治疗慢性乙型肝炎患者停药后复发的影响因素[J]. 新发传染病电子杂志, 2019, 4(1): 52-57.
[3]	蓝云翠, 刘曦, 丁立, 周耀勇, 夏瑾瑜. 611例CHB患者的临床指标与肝脏组织学关系研究[J]. 新发传染病电子杂志, 2017, 2(2): 72-75.